The bill amends Section 21-28-3.18 of the Uniform Controlled Substances Act, specifically addressing the handling of prescriptions for testosterone. It introduces provisions that prohibit the transmission and reporting of testosterone prescriptions within the prescription drug monitoring database maintained by the Department of Health. Additionally, it mandates that the Department of Health and Human Services purge all existing records related to the prescribing and dispensing of testosterone from the controlled substances prescriptions monitoring program immediately upon the effective date of this subsection. The bill ensures that no further records concerning the prescribing or dispensing of testosterone are created or maintained by the electronic prescription drug monitoring program. The act is set to take effect on July 1, 2027.

Statutes affected:
2889: 21-28-3.18
2889  SUB A: 21-28-3.18